Informație de încredere. Sprijin real.

Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.

Spațiu publicitar disponibil — bannerul mare de susSpațiu publicitar disponibil — bannerul mare de sus

Explorează temele

Caută tot →

Sănătate mintală și neurodezvoltare

Afecțiuni neurologice

Articole și ghiduri recomandate

StudiuDepresieÎncredere înaltă26.06.2026

Psychiatric Comorbidities Associated with Hormonal Contraceptive Use: A Scoping Review and Meta-Analysis (2014–2024)

This systematic scoping review synthesized evidence from 46 studies (2014–2024) on associations between hormonal contraceptive use and psychiatric outcomes. Meta-analysis found small but statistically significant increases in depressive symptoms with progestin-only methods (RR=1.24) and inconsistent evidence for anxiety and suicidality, with high heterogeneity across studies highlighting the need for individual risk assessment.

PresăDepresieÎncredere bună25.06.2026

Personalized Brain Imaging to Guide Transcranial Magnetic Stimulation for Treatment-Resistant Depression

A randomized clinical trial from Mass General Brigham demonstrates that using personalized brain imaging to tailor transcranial magnetic stimulation (TMS) treatment may enhance outcomes for patients with treatment-resistant depression. The findings, published in JAMA Psychiatry, suggest individualized neuroimaging-guided approaches could improve the efficacy of this FDA-approved therapeutic intervention.

StudiuDepresieÎncredere bună22.06.2026

Editorial: Neurocognitive Disorders and Depression—Complex Interrelationships

This editorial examines the intricate connections between neurocognitive disorders and depression, highlighting how these conditions frequently co-occur and influence one another. The piece addresses the clinical and research implications of understanding these interrelationships for improved patient assessment and treatment approaches.

StudiuDepresieÎncredere înaltă22.06.2026

CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk

This study identifies a genetic variant (CALHM2 V136G) that impairs ATP release from brain cells and is associated with both depression and Alzheimer's disease risk. Using engineered mouse models, researchers demonstrated that this mutation causes depressive-like behaviors and cognitive decline, which could be reversed by ATP supplementation, suggesting a novel biological mechanism linking depression to neurodegeneration.